‘Absolutely tiny’ Federal obesity funding challenged Questions have been raised about why no weight loss drugs are on the PBS, as research highlights the lack of funding for obesity prevention.
Semaglutide shortage sparks patient demands for alternatives But in Australia, the new drug generating the most interest is still in its infancy – and not yet listed on the PBS.
What GPs need to know about obesity and its treatment SPONSORED: Obesity is a global epidemic caused by many factors. The disease, and how surgery and adjunct therapies fit in, should be understood.
Viral weight loss drug linked to pancreatitis Semaglutide could be putting patients at greater risk of severe gastrointestinal complications when used for obesity management.
WONCA obesity panel set to tackle growing issue An international group of experts will explore various elements of a chronic health issue that is becoming increasingly prevalent.
In Practice: Children with suspected serious bacterial infection GPs have been issued a reminder about swift antibiotic treatment in paediatric cases of serious bacterial infection.
Global diabetes cases to reach 1.3 billion by 2050: Study There are countries where as many as one in five people could be living with diabetes if current trends continue.
How should GPs discuss weight with their patients? A high-profile body image advocate wants doctors to stop raising the issue, but clinicians say there are ways to sensitively approach the topic.
‘We need to act’: Junk food advertising bill tabled Proposed new laws would stop unhealthy food from being advertised from 6.00 am – 9.30 pm to help protect children.
Obesity found to speed up loss of immunity from COVID vaccines COVID vaccines are very effective, but new research suggests the immune response is not as strong in some groups.